AnxA2-Mediated MMP-9 Activation Drives Semaglutide’s Retinal Protection #sciencefather #Semaglutide
This study reveals that semaglutide protects against retinal vascular damage in diabetic retinopathy by activating MMP-9 through AnxA2 signaling. The findings highlight a novel mechanism involving basement membrane remodeling, offering new therapeutic insights into vision preservation in diabetes.
Visit Our Website : http://biotechnologyscientist.com
Contact Us : support@biotechnologyscientist.com Nomination Link : https://biotechnologyscientist.com/award-nomination/?ecategory=Awards&rcategory=Awardee #Semaglutide #DiabeticRetinopathy #RetinalHealth #AnxA2 #MMP9 #BasementMembrane #VascularRemodeling #OphthalmologyResearch #DiabetesResearch #RetinalTherapy #GLP1Analog #VascularIntegrity #EyeHealth #RetinalProtection #BiomedicalResearch #Neovascularization #EndothelialFunction #VisionPreservation #TranslationalMedicine #MolecularMechanism
Comments
Post a Comment